LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations

Author(s):  Okeke Claudia C, Medwick Thomas, Nairn Graham, Shaila Khuspe, Grady Lee T

Issue:  Jul/Aug 2003 - After the Women's Health Initiative Trial
View All Articles in Issue

Abstract:  The objective of this study was to evaluate the chemical stability of hydralazine hydrochloride 0.1% and 1% when prepared extemporaneously from commercially available hydralazine bulk powder. The oral solutions were prepared to contain preservatives, sweeteners, a humectant and diluting agents. They were prepared flavored and nonflavored and stored in duplicate glass and plastic bottles. Each of the flavored preparations was stored at 5°C, 25°C/60% relative humidity and 40°C/75% relative humidity. Samples from the bottles of concentrations stored under these conditions were taken for a period of up to 92 days. Each of the nonflavored preparations was stored at 5°C. Samples from the bottles stored under these conditions were taken for a period of up to 72 days. Samples were taken from glass and plastic bottles on the designated sampling days for both flavored and nonflavored preparations, and the samples were analyzed for drug concentration using a stability-indicating high-pressure liquid chromatography analytical technique. Degradation occurred faster in the 0.1% oral solution than in the 1% solution at all the studied conditions. At 40°C, a considerable amount of drug loss was observed for both the 0.1% and the 1% oral solutions for the flavored preparations. For both flavored and nonflavored preparations, the lowest studied temperature condition (5°C) appeared to be the most favorable for the preparations, with 93% or more of the initial potency retained by day 29.

Related Keywords: Hydralazine hydrochloride, stability of, Stability of hydralazine hydrochloride

Related Categories: GERIATRICS, PEDIATRICS, PEER-REVIEWED

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations Okeke Claudia C, Medwick Thomas, Nairn Graham, Shaila Khuspe, Grady Lee T Jul/Aug 2003 313-319 Buy
Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid Allen Loyd V Jr Nov/Dec 2006 457 Buy
Hydralazine Hydrochloride 20-mg/mL Injection Allen Loyd V Jr Jan/Feb 2015 65 Buy
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes Xu Quanyun A, Trissel Lawrence A, Pham Lien Jan/Feb 2002 66-69 Buy
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Bupivacaine Hydrochloride Packaged in Plastic Syringes Trissel Lawrence A, Xu Quanyun A, Pham Lien Jan/Feb 2002 70-73 Buy
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Alexander Kenneth S, Thyangarajapuram N Sep/Oct 2003 389-393 Buy
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A May/Jun 2005 238-241 Buy
Stability of Lidocaine Hydrochloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes Storms Meredith L, Stewart James T, Warren Flynn W Sep/Oct 2002 388-390 Buy
Physical and Chemical Stability of Hydromorphone Hydrochloride 1.5- and 80-mg/mL Packaged in Plastic Syringes Trissel Lawrence A, Xu Quanyun A, Pham Lien Jan/Feb 2002 74-76 Buy
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A Mar/Apr 2008 170-173 Buy